Novartis discontinues Estraderm patches

Product Novartis has announced it will be discontinuing its estrogen patches Estraderm TTS 25 and 100 as of January 1.

Novartis has announced it will be discontinuing its estrogen patches Estraderm TTS 25 and 100 as of January 1.

The manufacturer said it was scrapping the products because of "commercial reasons" but expected stock to still be available in early 2012. Novartis advised patients using the patches to speak to their doctor about their treatment.

Pharmacists can contact the Novartis medical information department for further information on 01276 698370.

Latest from News

More from Clinical